Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rate versus rhythm control strategies for AF.

Brian Olshansky1

  • 1Division of Cardiology, University of Iowa Hospitals, 200 Hawkins Drive, Iowa City, IA 52242, USA. brian-olshansky@uiowa.edu

Current Treatment Options in Cardiovascular Medicine
|September 6, 2005
PubMed
Summary

For elderly patients with atrial fibrillation (AF), the safest approach combines medication-based rate control with warfarin anticoagulation. Advanced procedures like ablation may be needed if medical management is insufficient for persistent AF.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What are we treating? The need for broader provider understanding of POTS, its nature, and care.

The American journal of medicine·2026
Same author

Indications, contraindications, and step-by-step methodology for performing carotid sinus massage in patients presenting with syncope : A scientific statement of an Ad Hoc Syncope Consortium endorsed by: the European Autonomic Society (EFAS), Gruppo Italiano Multidisciplinare Syncope (GIMSI) and European Geriatric Medicine Society (EuGMS).

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2026
Same author

Clinical outcomes of rate control versus rhythm control as the initial strategy in atrial fibrillation: insights from the GLORIA-AF registry.

Internal and emergency medicine·2026
Same author

Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III.

Journal of the American Heart Association·2026
Same author

Stylet-in-sheath: A new solution to an old problem?

Heart rhythm·2026
Same author

Sham-controlled trials and the future of electrophysiology: Reflections on SHAM-PFA.

Heart rhythm O2·2025

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) is a common arrhythmia, particularly in the elderly.
  • Managing AF in older adults presents unique challenges due to comorbidities and medication considerations.
  • Persistent or recurrent AF episodes necessitate effective long-term management strategies.

Purpose of the Study:

  • To outline the safest long-term management strategy for elderly patients experiencing persistent or recurrent atrial fibrillation.
  • To identify when advanced interventions are indicated for rate control in AF patients.
  • To differentiate appropriate management for younger versus elderly AF patients with significant symptoms.

Main Methods:

  • Review of current medical literature and clinical guidelines for AF management in the elderly.

Related Experiment Videos

  • Analysis of treatment outcomes for rate control versus rhythm control strategies.
  • Evaluation of the role of oral anticoagulation (warfarin) and interventional procedures.

    • Main Results:

    • Careful rate control with medications and warfarin anticoagulation is identified as the safest long-term strategy for elderly AF patients.
    • Atrioventricular junctional ablation with pacemaker implantation is a viable option for refractory cases.
    • Rhythm control strategies are more appropriate for younger patients or select elderly patients with severe, AF-related symptoms.

    Conclusions:

    • A conservative rate-control approach with anticoagulation is paramount for long-term AF management in the elderly.
    • Interventional therapies serve as crucial alternatives when medical management fails to achieve adequate rate control.
    • Personalized treatment decisions are essential, balancing symptom burden, age, and therapeutic options for atrial fibrillation.